DNA Methylation Aberrant in Atherosclerosis.

DNA methylation aging atherosclerosis hyperhomocysteinemia oxidative stress

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 16 11 2021
accepted: 24 01 2022
entrez: 21 3 2022
pubmed: 22 3 2022
medline: 22 3 2022
Statut: epublish

Résumé

Atherosclerosis (AS) is a pathological process involving lipid oxidation, immune system activation, and endothelial dysfunction. The activated immune system could lead to inflammation and oxidative stress. Risk factors like aging and hyperhomocysteinemia also promote the progression of AS. Epigenetic modifications, including DNA methylation, histone modification, and non-coding RNA, are involved in the modulation of genes between the environment and AS formation. DNA methylation is one of the most important epigenetic mechanisms in the pathogenesis of AS. However, the relationship between the progression of AS and DNA methylation is not completely understood. This review will discuss the abnormal changes of DNA methylation in AS, including genome-wide hypermethylation dominating in AS with an increase of age, hypermethylation links with methyl supply and generating hyperhomocysteinemia, and the influence of oxidative stress with the demethylation process by interfering with the hydroxyl-methylation of TET proteins. The review will also summarize the current status of epigenetic treatment, which may provide new direction and potential therapeutic targets for AS.

Identifiants

pubmed: 35308237
doi: 10.3389/fphar.2022.815977
pii: 815977
pmc: PMC8927809
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

815977

Informations de copyright

Copyright © 2022 Dai, Chen and Xu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2031-2041
pubmed: 31116040
Atherosclerosis. 2019 Feb;281:168-179
pubmed: 30591183
Genes (Basel). 2019 Feb 23;10(2):
pubmed: 30813436
Atherosclerosis. 2019 Jan;280:183-191
pubmed: 30529831
Life Sci. 2021 Jan 15;265:118756
pubmed: 33189816
Int J Cardiol Heart Vasc. 2018 Sep 25;21:36-44
pubmed: 30276232
Nutr Metab Cardiovasc Dis. 2014 May;24(5):483-8
pubmed: 24418380
Free Radic Biol Med. 2015 May;82:22-8
pubmed: 25656994
Cardiovasc Res. 2012 Jul 15;95(2):241-50
pubmed: 22492673
Evid Based Complement Alternat Med. 2021 Jun 23;2021:6623657
pubmed: 34257689
Aging Cell. 2020 Apr;19(4):e13127
pubmed: 32107839
Blood. 2021 Apr 22;137(16):2161-2170
pubmed: 33171487
Atherosclerosis. 2021 Apr;323:37-43
pubmed: 33780749
EBioMedicine. 2021 Jan;63:103151
pubmed: 33279859
Medicina (Kaunas). 2018 May 28;54(3):
pubmed: 30344267
BMC Med Genomics. 2015 Feb 27;8:7
pubmed: 25881171
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
J Cell Biol. 2015 Apr 13;209(1):13-22
pubmed: 25869663
BMC Cardiovasc Disord. 2021 Nov 19;21(1):554
pubmed: 34798829
J Clin Invest. 2018 Jun 1;128(6):2473-2486
pubmed: 29558369
Pharmacol Ther. 2020 Jun;210:107514
pubmed: 32105674
Int J Cardiol. 2017 Jan 15;227:66-82
pubmed: 27852009
Biores Open Access. 2013 Apr;2(2):118-27
pubmed: 23593564
PLoS One. 2014 Aug 01;9(8):e102265
pubmed: 25084356
Clin Epigenetics. 2021 Oct 9;13(1):186
pubmed: 34627379
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1936-42
pubmed: 23723375
High Blood Press Cardiovasc Prev. 2020 Oct;27(5):363-371
pubmed: 32740853
Cell. 2011 Sep 16;146(6):866-72
pubmed: 21925312
Circ Res. 2018 Sep 14;123(7):773-786
pubmed: 30355081
Clin Res Cardiol. 2021 Oct;110(10):1554-1563
pubmed: 33686472
Int J Biochem Cell Biol. 2019 Feb;107:27-31
pubmed: 30543933
Medicine (Baltimore). 2021 Mar 19;100(11):e24769
pubmed: 33725943
Circulation. 2019 May 7;139(19):2260-2277
pubmed: 30773021
Nat Commun. 2020 Jul 22;11(1):3671
pubmed: 32699299
Endocrinology. 2014 Dec;155(12):4925-38
pubmed: 25251587
Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):623-634
pubmed: 30760015
J Mol Cell Cardiol. 2019 Aug;133:148-163
pubmed: 31211956
Cancer Cell. 2011 Nov 15;20(5):606-19
pubmed: 22094255
J Hypertens. 2015 Sep;33(9):1897-906; discussion 1906
pubmed: 26147383
J Clin Invest. 2007 Jan;117(1):195-205
pubmed: 17200719
Redox Biol. 2020 Jan;28:101322
pubmed: 31605963
Molecules. 2021 Jan 01;26(1):
pubmed: 33401401
Hum Mol Genet. 2016 Nov 1;25(21):4739-4748
pubmed: 28172975
Nature. 2019 Jul;571(7766):489-499
pubmed: 31341302
Circ Res. 2021 Dec 3;129(12):e215-e233
pubmed: 34702049
Oxid Med Cell Longev. 2016;2016:8627384
pubmed: 26989455
Vascul Pharmacol. 2007 Jul;47(1):1-9
pubmed: 17433786
Circ Cardiovasc Genet. 2014 Oct;7(5):692-700
pubmed: 25091541
Science. 2009 May 15;324(5929):930-5
pubmed: 19372391
Biochimie. 2016 Jun;125:281-96
pubmed: 26717905
Epigenetics. 2019 Dec;14(12):1141-1163
pubmed: 31284823
Mol Med Rep. 2014 Aug;10(2):947-54
pubmed: 24841643
Circ Res. 2016 Feb 19;118(4):653-67
pubmed: 26892964
Am J Nephrol. 2006;26(6):531-5
pubmed: 17159340
Cardiovasc Ther. 2017 Jun;35(3):
pubmed: 28371472
Sci Rep. 2016 Aug 17;6:30053
pubmed: 27530451
Pharmacol Res. 2017 Feb;116:57-69
pubmed: 27988384
Int J Environ Res Public Health. 2019 Jul 03;16(13):
pubmed: 31277270
Rev Cardiovasc Med. 2019 Mar 30;20(1):19-25
pubmed: 31184092
Sci Rep. 2019 Feb 5;9(1):1429
pubmed: 30723273
Nat Rev Genet. 2021 Jan;22(1):59-66
pubmed: 33024290
J Mol Biol. 2021 Mar 19;433(6):166659
pubmed: 33010306
Redox Biol. 2020 May;32:101444
pubmed: 32067910
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1854-1869
pubmed: 32580634
Mol Neurobiol. 2019 Jun;56(6):4175-4191
pubmed: 30288696
Nutr Metab (Lond). 2012 Mar 29;9(1):25
pubmed: 22458435
Nucleic Acids Res. 2019 Jan 10;47(1):152-167
pubmed: 30321403
DNA Cell Biol. 2018 Jun;37(6):517-523
pubmed: 29653065
Br J Nutr. 2018 Nov;120(9):961-976
pubmed: 30355391
Cardiovasc Res. 2013 Jul 15;99(2):315-27
pubmed: 23619421
Nat Immunol. 2018 Jan;19(1):10-19
pubmed: 29242543
Aging Cell. 2015 Dec;14(6):924-32
pubmed: 25913071
Circ Res. 2020 Jan 31;126(3):298-314
pubmed: 31818196
Int J Mol Sci. 2021 Jan 12;22(2):
pubmed: 33445687
Genome Med. 2020 Sep 28;12(1):84
pubmed: 32988399
Front Pharmacol. 2021 Dec 22;12:787541
pubmed: 35002720
Life (Basel). 2021 Jan 15;11(1):
pubmed: 33467601
Herz. 2018 Nov;43(7):656-662
pubmed: 28884387
Clin Chem. 2013 Aug;59(8):1166-74
pubmed: 23529703
Inflammation. 2017 Oct;40(5):1589-1598
pubmed: 28578476
Trends Mol Med. 2017 Apr;23(4):332-347
pubmed: 28291707
Circ Cardiovasc Genet. 2017 Jan;10(1):
pubmed: 28213390
Aging Clin Exp Res. 2021 Apr;33(4):737-745
pubmed: 31811572
Curr Atheroscler Rep. 2015;17(2):476
pubmed: 25433555
Mol Biol Res Commun. 2018 Jun;7(2):59-65
pubmed: 30046619
Essays Biochem. 2019 Dec 20;63(6):717-726
pubmed: 31782496
Front Nutr. 2019 Apr 24;6:49
pubmed: 31069230
Int J Mol Med. 2018 Jan;41(1):220-232
pubmed: 29115576
Eur Heart J. 2015 Apr 21;36(16):993-1000
pubmed: 25411193
Mol Cell. 2018 Sep 20;71(6):882-895
pubmed: 30241605
Circulation. 2002 Oct 8;106(15):1999-2003
pubmed: 12370226
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
J Am Coll Cardiol. 2019 Sep 10;74(10):1352-1365
pubmed: 31488273
J Gene Med. 2021 Aug;23(8):e3346
pubmed: 33885177
Mol Cell Biol. 2003 Aug;23(16):5594-605
pubmed: 12897133
Gene. 2014 May 10;541(1):31-40
pubmed: 24582973
J Diabetes. 2016 Jul;8(4):568-78
pubmed: 26333348
Clin Chim Acta. 2021 Jan;512:7-11
pubmed: 33232735
N Engl J Med. 1986 Oct 23;315(17):1046-51
pubmed: 3093861
Int J Mol Sci. 2016 Oct 20;17(10):
pubmed: 27775595
Nat Rev Cardiol. 2019 Apr;16(4):203-212
pubmed: 30467329

Auteurs

Yao Dai (Y)

Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Danian Chen (D)

Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Tingting Xu (T)

Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Classifications MeSH